Quantcast

Latest pharmaceutical Stories

2014-07-30 16:30:01

MISSISSAUGA, ON, July 30, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced its financial and operational results for the second quarter ended June 30, 2014. WF10 Phase 2 Clinical Trial Update The enrolment for the Phase 2 WF10 clinical trial for the treatment of allergic rhinitis commenced in March 2014 and to-date, 121 patients have been enrolled at 15 sites in...

2014-07-24 08:31:56

The Shared Investigator Platform, Built as an Industry Utility, Will Help Accelerate the Development of New Medicines TEANECK, N.J., July 24, 2014 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a first-of-its-kind, subscription-based platform that will transform the way clinical sites collaborate with...

2014-07-24 08:31:43

SAN DIEGO, July 24, 2014 /PRNewswire/ -- Cypher Genomics, Inc., the genome informatics company, announced today a co-promotion agreement with Illumina to facilitate the development of genomic-based biomarkers from whole genome sequence data for precision medicine and clinical trials. Cypher Genomics and Illumina will jointly offer pharmaceutical companies, through Illumina's sales force, a solution including Illumina's market leading sequencing technology, the NextBio platform for...

2014-07-23 23:17:41

Davron Technologies has been awarded a contract to design and manufacture three batch drying ovens for a leading pharmaceutical company. Chattanooga, Tennessee (PRWEB) July 22, 2014 Davron Technologies, Inc. has been selected by a leading pharmaceutical company to design and manufacture three batch drying ovens. The customer chose Davron because of the industrial oven solutions provider’s experience building ovens for the pharmaceutical industry and its level of commitment to quality in...

2014-07-22 08:31:25

SHANGHAI, July 22, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quarter of 2014 after the New York Stock Exchange closes on Wednesday, August 13, 2014 (which will be Thursday morning, August 14, 2014 Shanghai time). The earnings release will be available on the...

2014-07-20 23:00:10

Membrane filtration is a widely used separation technique in the pharmaceutical and biotechnology industries and its adoption rate in Europe and North America is very high - http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-membrane-filtration-market-255408031.html. (PRWEB) July 21, 2014 The “Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein...

2014-07-14 08:26:06

U.S. District Court for the District of Delaware Concurrently Denies Motion For Preliminary Injunction Filed by Antares Pharma, Inc. CHICAGO, July 14, 2014 /PRNewswire/ -- Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced that the U.S. Food and Drug Administration (FDA) has approved Rasuvo(TM), a subcutaneous injectable methotrexate (MTX) therapy delivered in an auto-injector...

2014-07-07 04:20:56

- MAA submission triggers $5 million milestone payment to AcelRx REDWOOD CITY, Calif. and AACHEN, Germany, July 7, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) and Grunenthal Group announced today that Grunenthal has submitted a Marketing Authorization Application (MAA) to the European Medicines Authority for ZALVISO(TM) for the management of moderate to severe acute pain in adult patients in a medically supervised environment. ZALVISO(TM) is a drug-device...

2014-07-01 08:30:06

- Creates an Innovative New Model in Specialty Pharmaceuticals Leadership - DUBLIN, July 1, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has completed the acquisition of Forest Laboratories, Inc. (NYSE: FRX) in a cash and equity transaction currently valued at approximately $28 billion. The combination creates one of the world's fastest-growing specialty pharmaceutical companies, with annual revenues of more than $15 billion anticipated for 2015. In...

2014-06-30 23:23:32

Membrane filtration is a widely used separation technique in the pharmaceutical and biotechnology industries, and its adoption rate in Europe and North America is very high. http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-membrane-filtration-market-255408031.html (PRWEB) June 30, 2014 The “Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nan filtration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related